4-Chloro-6-(2-methoxyethoxy)quinazoline, 95.0%, 1g

(2R,3R)-3-((S)-1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)-3-methoxy-2-methylpropanoic acid, 95.0%, 500mg

Trimethyl(4-vinylphenyl)silane (stabilized with TBC)>95.0%(GC)1g

Pefabloc® SC-Protease Inhibitor, 1 g

1-(4-METHYLPYRIMIDIN-2-YL)METHANAMINE HCL, 95.0%, 250mg

5-(Hydroxymethyl)nicotinonitrile, 95.0%, 5g

4-Chloro-2-methylthieno[2,3-d]pyrimidine, 97.0%, 1g

2-(2,3-Dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 10g

(3R,7aS)-3-(Trichloromethyl)tetrahydropyrrolo[1,2-c]oxazol-1(3H)-one, 98.0%, 25g

2,8-Dichloro-5-methoxyquinoline, 97%, 250mg

2-Aminomethyl-3-chloropyridine, 95.0%, 1g

4-[5-(2,2,2-Trifluoroethyl)-1,2,4-oxadiazol-3-yl]piperidine hydrochloride, 1g

6-Bromo-2,3-dihydro-benzo[1,4]dioxine-5-carboxylic acid, 98%, 250mg